What question did this study set out to answer?

This research investigates the prevalence and implications of diabetes, hypertension, and cardiovascular disease in patients with COPD. It aims to assess how lung function relates to these comorbidities and their adverse outcomes.

June 25, 2008European Respiratory JournalOpen Access

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

View Full Paper

Ask AI

Bookmark

This research investigates the prevalence and implications of diabetes, hypertension, and cardiovascular disease in patients with COPD. It aims to assess how lung function relates to these comorbidities and their adverse outcomes.
Data analyzed from 20,296 subjects aged ≥45 years in the ARIC and CHS studies.
Subjects were stratified based on baseline lung function using modified GOLD criteria.
Logistic regression models adjusted for age, sex, race, smoking, body mass index, and education were employed.
Subjects with GOLD stage 3 or 4 COPD had a higher prevalence of diabetes (OR 1.5, 95% CI 1.1-1.9).
Increased prevalence of hypertension was noted (OR 1.6, 95% CI 1.3-1.9).
Higher cardiovascular disease prevalence was recorded (OR 2.4, 95% CI 1.9-3.0).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial analyzes comorbidity outcomes in COPD patients, suggesting lung function impacts health risks.

Cite This Study

Mannino et al. (2008) studied this question.

synapsesocial.com/papers/69d56eb575589c71d767d556 https://doi.org/10.1183/09031936.00012408

View Full Paper

Ask AI

Bookmark

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

Key Points

Discussion

Implication

Cite This Study

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider